Chemoinformaics analysis of NEROLIDYL PROPIONATE
| Molecular Weight | 278.436 | nRot | 9 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 4 |
| Exact Molecular Weight | 278.225 | nRing | 0 |
| Solubility: LogS | -5.342 | nHRing | 0 |
| Solubility: LogP | 5.782 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 51.6678 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.419 |
| Synth | 3.5 |
| Natural Product Likeliness | 2.307 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.822 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.513 |
| MDCK | 0.0000209 |
| BBB | 0.06 |
| PPB | 0.912499 |
| VDSS | 2.479 |
| FU | 0.0638947 |
| CYP1A2-inh | 0.586 |
| CYP1A2-sub | 0.13 |
| CYP2c19-inh | 0.543 |
| CYP2c19-sub | 0.811 |
| CYP2c9-inh | 0.387 |
| CYP2c9-sub | 0.549 |
| CYP2d6-inh | 0.282 |
| CYP2d6-sub | 0.067 |
| CYP3a4-inh | 0.854 |
| CYP3a4-sub | 0.303 |
| CL | 11.138 |
| T12 | 0.206 |
| hERG | 0.03 |
| Ames | 0.002 |
| ROA | 0.008 |
| SkinSen | 0.952 |
| Carcinogencity | 0.219 |
| EI | 0.555 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.69546 |